RNase L Antibodies

Santa Cruz Biotechnology provides a broad selection of RNase L monoclonal antibodies for the detection and analysis of RNase L, a crucial enzyme involved in the antiviral response and regulation of cellular RNA levels. RNase L monoclonal antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RNase L plays a significant role in the innate immune response by degrading viral RNA, thereby limiting viral replication and spread. RNase L is involved in the regulation of apoptosis and cellular stress responses, making it a key focus in cancer research and therapeutic development. Understanding the function and regulation of RNase L is essential for elucidating its role in various diseases, including viral infections and cancer. RNase L research continues to reveal new insights into cellular defense mechanisms and potential therapeutic targets. Ongoing studies of RNase L expression patterns help identify biomarkers for disease progression and treatment response. RNase L investigation advances our understanding of RNA metabolism and cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of RNase L and its impact on human health.